Evaluation of a multiplex PCR assay for detection of cytomegalovirus in stool samples from patients with ulcerative colitis

Figure 1 Comparison of prevalence rate of cytomegalovirus infection. The prevalence rate was significantly higher in the immunocompromised patients than in the immunocompetent patients. CMV: Cytomegalovirus.

Figure 2 Comparison of prevalence rate of cytomegalovirus infection in 3 groups, including the immunocompetent patients excluding ulcerative colitis, the immunocompromised patients excluding ulcerative colitis, and ulcerative colitis patients. CMV: Cytomegalovirus.

Figure 3 Comparison of prevalence rate of cytomegalovirus infection. The prevalence rate was significantly higher in ulcerative colitis active patients than in ulcerative colitis inactive patients. CMV: Cytomegalovirus.

Figure 4 Comparison of prevalence rate of cytomegalovirus infection in 4 groups, including, ulcerative colitis inactive patients with immunosuppressive drugs, ulcerative colitis inactive patients without immunosuppressive drugs, ulcerative colitis active patients with immunosuppressive drugs, and ulcerative colitis active patients without immunosuppressive drugs. CMV: Cytomegalovirus.

Figure 5 Comparison of prevalence rate of Epstein-Barr virus infection in 3 groups, including the immunocompetent patients excluding ulcerative colitis, the immunocompromised patients excluding ulcerative colitis, and ulcerative colitis patients. EBV: Epstein-Barr virus.

Figure 6 Comparison of prevalence rate of human herpes virus-6 infection in 3 groups, including the immunocompetent patients excluding ulcerative colitis, the immunocompromised patients excluding ulcerative colitis, and ulcerative colitis patients. HHV6: Human herpes virus-6.

Figure 7 Overlapping prevalence patterns for cytomegalovirus, Epstein-Barr virus, and human herpes virus-6 infection in active ulcerative colitis patients. CMV: Cytomegalovirus; EBV: Epstein-Barr virus; HHV6: Human herpes virus-6.

Figure 8 Overlapping prevalence patterns for cytomegalovirus, Epstein-Barr virus, and human herpes virus-6 infection in the immunocompromised patients excluding ulcerative colitis. CMV: Cytomegalovirus; EBV: Epstein-Barr virus; HHV6: Human herpes virus-6.